yes, and that was a few months back now?
We’ve since had the EFS study and the 30 days follow up as well. The market for VIV also may have also expanded due to one valve being removed due to failures.
I’d be interest if they considered the risk markedly reduced and hence an increased NPV with the state of our EFS success.
- Forums
- ASX - By Stock
- Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
AVR
anteris technologies global corp.
Add to My Watchlist
0.83%
!
$6.05

yes, and that was a few months back now?We’ve since had the EFS...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.05 |
Change
0.050(0.83%) |
Mkt cap ! $93.76M |
Open | High | Low | Value | Volume |
$6.00 | $6.06 | $6.00 | $29.76K | 4.943K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 92 | $6.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.14 | 2634 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 92 | 6.000 |
2 | 608 | 5.910 |
1 | 600 | 5.900 |
1 | 25 | 5.850 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.140 | 2634 | 2 |
6.150 | 218 | 1 |
6.160 | 20 | 1 |
6.200 | 1000 | 1 |
6.220 | 128 | 1 |
Last trade - 13.46pm 24/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |